Pembrolizumab in Head and Neck Cancer—Promise and Price

作者：Lauren E. Miller, James W. Rocco, Vinay K. Rathi · 发表于：JAMA Otolaryngology–Head & Neck Surgery · 年份：2025 · DOI：10.1001/jamaoto.2025.4624 · 被引用次数：1 · 研究领域：Head and Neck Cancer Studies、Cancer Immunotherapy and Biomarkers、Economic and Financial Impacts of Cancer

This Viewpoint considers the financial impact of expanding the indication of pembrolizumab for treatment of resectable locally advanced head and neck squamous cell carcinoma expressing programmed cell death 1 ligand 1.